Premium
The apoptosis modulator and tumour suppressor protein RBM5 is a phosphoprotein
Author(s) -
Shu Yanjun,
RintalaMaki Nina D.,
Wall Vanessa E.,
Wang Ke,
Goard Carolyn A.,
Langdon Colleen E.,
Sutherland Leslie C.
Publication year - 2006
Publication title -
cell biochemistry and function
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.933
H-Index - 61
eISSN - 1099-0844
pISSN - 0263-6484
DOI - 10.1002/cbf.1366
Subject(s) - phosphorylation , apoptosis , dephosphorylation , protein kinase b , cancer research , microbiology and biotechnology , phosphoprotein , cell cycle , biology , protein phosphorylation , kinase , chemistry , programmed cell death , cell growth , phosphatase , protein kinase a , biochemistry
RBM5/LUCA‐15/H37 is a nuclear SR‐related RNA binding protein with the ability to modulate both apoptosis and the cell cycle, and retard tumour formation. How RBM5 functions to carry out these, potentially interrelated, biological activities is unknown. Since reversible phosphorylation has been shown to play an important role in the regulation of SR protein function, apoptosis and cell cycle control, in an attempt to elucidate the underlying mechanisms regulating RBM5 function, the phosphorylation status of RBM5 was investigated. Whole cell lysate from growing cell cultures was treated with the broad phosphatase spectrum of CIP, resulting in a decrease in the molecular mass of RBM5. A similar decrease in molecular mass, of a subset of RBM5 proteins, was observed during growth factor deprivation, in a manner consistent with partial dephosphorylation of RBM5. Molecular mass increased upon growth factor addition, demonstrating that this apoptosis‐associated alteration in molecular mass was a reversible process. Immunoprecipitation and mutagenesis experiments strongly suggested that phosphotyrosines are not present in RBM5 under normal growth conditions, and that serine 69 is phosphorylated, but not by Akt kinase. Taken together, these results suggest that reversible phosphorylation of RBM5 is a mechanism capable of regulating RBM5 participation in modulating apoptosis, and perhaps tumour suppression. Copyright © 2006 John Wiley & Sons, Ltd.